Phathom Pharmaceuticals Appoints Sanjeev Narula as Chief Financial And Business Officer

Author: Benzinga Newsdesk | October 06, 2025 08:11am

• Sanjeev Narula brings proven success in scaling commercial-stage biopharma companies with expertise in capital and investor strategies, M&A, and operational excellence
  
   
• Appointment strengthens Phathom's leadership team and ability to execute its growth strategy in GI
   

FLORHAM PARK, N.J., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced the appointment of Sanjeev Narula as Chief Financial and Business Officer.

"We welcome Sanjeev to Phathom's leadership team at this important stage of our growth," said Steve Basta, President and Chief Executive Officer of Phathom. "His extensive financial and operational expertise will be critical as we execute our strategy to achieve profitability and drive long-term shareholder value."

Posted In: PHAT